Showing results (1621-1630 of 1,943) with videos related to
Sort By:
Pageof 195
Respiratory Research|October 4, 2013
Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cellsRoland F Hoffmann, Sina Zarrintan, Simone M Brandenburg, et al.Frontiers in Physics|November 23, 2020
Biomedical Research Programs at Present and Future High-Energy Particle AcceleratorsVincenzo Patera, Yolanda Prezado, Faical Azaiez, et al.Nature Communications|April 13, 2026
A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a studyNina Hertoghs, Chan Tang, Vitalija van Paassen, et al.Frontiers in Immunology|October 18, 2016
HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic AcidsFreek Cox, Ted Kwaks, Boerries Brandenburg, et al.Clinical Kidney Journal|April 13, 2019
Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney DiseasePablo A Ureña-Torres, Marc Vervloet, Sandro Mazzaferro, et al.The Journal of Clinical Investigation|September 20, 2016
Axial tubule junctions control rapid calcium signaling in atriaSören Brandenburg, Tobias Kohl, George S B Williams, et al.Trials|September 16, 2021
Improving the continuity and coordination of ambulatory care through feedback and facilitated dialogue-a study protocol for a cluster-randomised trial to evaluate the ACD study (Accountable Care in Germany)Leonie Sundmacher, Ronja Flemming, Verena Leve, et al.Applied Spectroscopy|December 9, 2003
In situ sensing of volatile organic compounds in groundwater: first field tests of a mid-infrared fiber-optic sensing systemH Steiner, M Jakusch, M Kraft, et al.Frontiers in Immunology|October 30, 2018
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in MiceJoan E M van der Lubbe, Johan W A Verspuij, Jeroen Huizingh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2022
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm StudyManuel Weber, David Kersting, Burkhard Riemann, et al.Pageof 195